Clinical Trials Logo

Lipemia clinical trials

View clinical trials related to Lipemia.

Filter by:
  • None
  • Page 1

NCT ID: NCT05539742 Completed - Lipemia Clinical Trials

Comparison of the Effect of MCFA and LCFA on Postprandial Appetite and Lipemia

Start date: June 1, 2022
Phase: N/A
Study type: Interventional

The main objective is to investigate if foods high in coconut oil (MCFA) or palm oil (LCFA) have different impacts on postprandial blood lipid levels and appetite via a visual analog scale (VAS).

NCT ID: NCT04688073 Completed - Clinical trials for Nutritional and Metabolic Diseases

Effect of Muscle Damage After Downhill Running on Postprandial Lipids

Start date: May 15, 2019
Phase: N/A
Study type: Interventional

All participants underwent three experimental trials, namely downhill running (DR), level running (LR), and the control (CON) in a cross-over design. Each trial lasted for 2 days. The participants were fed the same breakfast and lunch on day 1 in each trial. The participants arrived at the laboratory at 18:00 on day 1 and ran on the treadmill at 60% VO2max (downhill and level surface trials) or rested (CON trial) for 30 min. Subsequently, they were fed a standardized dinner (A meal box containing chicken, vegetables, and rice, 692 kcal, with 50% energy from carbohydrate, 32% from fat, and 18% from protein) within 20 min. The participants returned to the laboratory at 07:30 on day 2 after an overnight fast. After baseline blood and gas samples were collected, the participants were fed a high-fat meal that included cereal, white bread, whipping cream, cheese, and butter. The high-fat meal provided fat 1.2 g/kg (65% energy), carbohydrate 1.1 g/kg (27% energy), protein 0.33 g/kg (8% energy), and 16.5 kcal/kg. A 10-mL blood sample was collected from a forearm vein into nonheparinized tubes before and immediately after exercise or rest on day 1. On day 2, postprandial blood samples were collected from forearm veins into nonheparinized tubes by using an indwelling venous needle and a three-way stopcock. A 10-mL blood sample was collected before (0 h) and 0.5, 1, 2, 3, 4, 5, and 6 h after the high-fat meal.

NCT ID: NCT03958734 Completed - Clinical trials for Cardiovascular Risk Factor

Postprandial Monocyte Maturation and Vascular Dysfunction Following High-Fat Meals - Study 1

Start date: June 17, 2019
Phase: N/A
Study type: Interventional

The purpose of this research study is to examine the effect of high-fat meals on the health of blood vessels. In addition, the study will examine how exercise/fitness/physical activity impacts blood vessels after consumption of a high-fat meal.

NCT ID: NCT03501433 Completed - Aging Clinical Trials

Effects of Nicotinamide Riboside on Metabolism and Vascular Function

Start date: February 1, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the effects of Nicotinamide Riboside (NR) supplementation on metabolism and vascular function following high-fat meal. Differences between young (18-35) and older (60-75) adults will be determined.

NCT ID: NCT03439878 Completed - Clinical trials for Cardiovascular Risk Factor

Effect of Galactose Ingestion on Postprandial Lipemia

Start date: February 1, 2018
Phase: N/A
Study type: Interventional

This study aims to assess the postprandial triglyceride response to the ingestion of a high-fat meal with co-ingestion of either galactose, or glucose.

NCT ID: NCT01618071 Completed - Vasodilation Clinical Trials

Vascular Effects of Triglyceride-rich Lipoproteins

Start date: June 2012
Phase: N/A
Study type: Interventional

Many types of cardiovascular disease begin when the layer of cells lining blood vessels (endothelial cells) start to function abnormally. This causes white blood cells (monocytes) to enter the blood vessel wall and eventually form lesions. Fats from foods we consume are carried in the blood for 3-8 hours after a fatty meal in small particles known as chylomicrons (CM) and chylomicron remnants (CMR). The overall aim of this project is to investigate the idea that n-3 polyunsaturated fatty acids (PUFA) protect against heart disease by modifying the effect of CMR on endothelial cells and monocytes. We hypothesize that n3-PUFA carried in CMR reduce detrimental events which promote blood vessel damage and activate protective mechanisms to improve the function of arteries.

NCT ID: NCT00827307 Completed - Ultrasonography Clinical Trials

Zoladex Plus Tamoxifen in Breast Cancer

Start date: June 2008
Phase: N/A
Study type: Interventional

The purpose of this study is to compare Zoladex plus tamoxifen with tamoxifen alone as adjuvant hormonal therapy in pre- or perimenopausal women with early-stage breast cancer in terms of breast density, estrogen levels, lipidemia, endometrial thickness and ultrasonographic abnormalities.